Clinical Trial Update: Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC

View source ↗

Summary

Prospective study assessing safety of Deb-TACE with 100µ beads in patients with non-resectable hepatocellular carcinoma; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Deb-TACE with 100µ beads (Deb-TACE with 100µ beads)

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: Hepatocellular Carcinoma | Status: COMPLETED | Results posted: 2021-03-30